Roquette Concludes EUR 1.2 Billion Bond Offering

Roquette, a leader in plant-based ingredients and pharmaceutical excipients, has successfully completed its inaugural bond offering. The dual tranche bonds, totaling EUR 1.2 billion, will trade on Euronext Paris. Strong investor demand resulted in an order book exceeding EUR 3.1 billion, highlighting Roquette's global appeal. Proceeds are earmarked to refinance the planned acquisition of IFF Pharma Solutions, expected to finalize in early 2025.

CEO Pierre Courduroux expressed pride in the bond issuance, noting it marks a significant milestone for the company. He emphasized that the acquisition will enhance Roquette’s capabilities, providing a more balanced Health and Nutrition portfolio and expanded global presence.

Roquette, a family-owned company, continues its commitment to innovation and sustainable growth, entering public credit markets to support its investment strategies.